cRIPGBM T19250
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
cRIPGBM is a proapoptotic derivative of RIPGBM and a cell type-selective inducer of apoptosis in GBM cancer stem cells (CSCs) by binding to RIPK2 (EC50: 68 nM in GBM-1 cells).
CAS nr:
T19250
Purity:
98%
Molecular Weight:
393,46
SMILES:
O=C1C2=C([N+](CC3=CC=CC=C3)=C(C)N2CC4=CC=CC=C4)C(C5=C1C=CC=C5)=O
Formula:
C26H21N2O2
Pathway:
Apoptosis
Target:
TNF
